In individuals without established CVD but with multiple cardiovascular risk factors (such as age 55 years, obesity, hypertension, smoking, dyslipidaemia or albuminuria), a GLP-1 RA with proven benefit could be used to reduce MACE, or an SGLT2i with proven benefit could be used to reduce MACE and HF and improve kidney outcomes
A strong program should also focus on energy, mobility, blood pressure, blood sugar, cholesterol, waist circumference, confidence, and long-term sustainability
Semaglutide and Female Fertility The exploration into the effects of semaglutide on female fertility is both fascinating and imperative, given the increasing prevalence of obesity and metabolic disorders among women of reproductive age
Warning Signs When Choosing Semaglutide Injection Third-Party Manufacturer Importers and distributors should be cautious of manufacturers that show any of the following warning signs: Expired WHOGMP Certificates Outdated or invalid certification means the facility may not meet current global quality standards, risking regulatory rejection
